196 related articles for article (PubMed ID: 32938643)
1. Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study.
Cho MH; Yoo TG; Jeong SM; Shin DW
Cancer Prev Res (Phila); 2021 Jan; 14(1):95-104. PubMed ID: 32938643
[TBL] [Abstract][Full Text] [Related]
2. Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population-based cohort study in Korea with systematic review and meta-analysis.
Seo SI; Park CH; Kim TJ; Bang CS; Kim JY; Lee KJ; Kim J; Kim HH; You SC; Shin WG
Cancer Med; 2022 Feb; 11(4):1217-1231. PubMed ID: 34970858
[TBL] [Abstract][Full Text] [Related]
3. The Associations of Aspirin, Statins, and Metformin With Lung Cancer Risk and Related Mortality: A Time-Dependent Analysis of Population-Based Nationally Representative Data.
Kang J; Jeong SM; Shin DW; Cho M; Cho JH; Kim J
J Thorac Oncol; 2021 Jan; 16(1):76-88. PubMed ID: 32950701
[TBL] [Abstract][Full Text] [Related]
4. Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality.
Koo HY; Jeong SM; Cho MH; Chun S; Shin DW; Park J
Sci Rep; 2021 Aug; 11(1):16171. PubMed ID: 34373584
[TBL] [Abstract][Full Text] [Related]
5. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in HBV patients with statin and metformin use: a population-based cohort study.
Chen CI; Kuan CF; Fang YA; Liu SH; Liu JC; Wu LL; Chang CJ; Yang HC; Hwang J; Miser JS; Wu SY
Medicine (Baltimore); 2015 Feb; 94(6):e462. PubMed ID: 25674734
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Low-Dose Aspirin Use Reduces Gastric Cancer Incidence: A Nationwide Cohort Study.
Kim YI; Kim SY; Kim JH; Lee JH; Kim YW; Ryu KW; Park JH; Choi IJ
Cancer Res Treat; 2016 Apr; 48(2):798-805. PubMed ID: 26194372
[TBL] [Abstract][Full Text] [Related]
8. Statins and the risk of gastric, colorectal, and esophageal cancer incidence and mortality: a cohort study based on data from the Korean national health insurance claims database.
Kim DS; Kim HJ; Ahn HS
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2855-2865. PubMed ID: 35660949
[TBL] [Abstract][Full Text] [Related]
9. Statins Were Associated with a Reduced Gastric Cancer Risk in Patients with Eradicated
Cheung KS; Chan EW; Wong AYS; Chen L; Seto WK; Wong ICK; Leung WK
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):493-499. PubMed ID: 31792089
[TBL] [Abstract][Full Text] [Related]
10. Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study.
Kim YI; Kim SY; Cho SJ; Park JH; Choi IJ; Lee YJ; Lee EK; Kook MC; Kim CG; Ryu KW; Kim YW
Aliment Pharmacol Ther; 2014 Apr; 39(8):854-63. PubMed ID: 24612291
[TBL] [Abstract][Full Text] [Related]
11. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
Choi JH; Lee SH; Huh G; Chun JW; You MS; Paik WH; Ryu JK; Kim YT
Cancer Med; 2019 Dec; 8(17):7419-7430. PubMed ID: 31637875
[TBL] [Abstract][Full Text] [Related]
12. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
13. Metformin use reduced the risk of stomach cancer in diabetic patients in Korea: an analysis of Korean NHIS-HEALS database.
Kim J; Hyun HJ; Choi EA; Kim Y; Bae YJ; Kang HT
Gastric Cancer; 2020 Nov; 23(6):1075-1083. PubMed ID: 32462322
[TBL] [Abstract][Full Text] [Related]
14. Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer.
Kim MH; Chang J; Kim WJ; Banerjee S; Park SM
Am J Gastroenterol; 2018 Jun; 113(6):845-854. PubMed ID: 29855546
[TBL] [Abstract][Full Text] [Related]
15. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
Tseng CH
Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
[TBL] [Abstract][Full Text] [Related]
16. Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.
McNamara MG; Aneja P; Le LW; Horgan AM; McKeever E; Knox JJ
Hepatogastroenterology; 2015 May; 62(139):564-9. PubMed ID: 26897929
[TBL] [Abstract][Full Text] [Related]
17. Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.
Majidi A; Na R; Dixon-Suen S; Jordan SJ; Webb PM
Gynecol Oncol; 2020 Jun; 157(3):678-685. PubMed ID: 32317171
[TBL] [Abstract][Full Text] [Related]
18. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin.
Haukka J; Niskanen L; Auvinen A
Int J Cancer; 2017 Dec; 141(12):2437-2449. PubMed ID: 28840596
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
[TBL] [Abstract][Full Text] [Related]
20. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.
Löfling LL; Støer NC; Andreassen BK; Ursin G; Botteri E
Breast Cancer Res; 2023 Aug; 25(1):101. PubMed ID: 37649039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
